| 1 | [SID103310643] | Unspecified | | | Second-order rate constant (M-1 s-1) for the alkaline hydrolysis in water at 30 degrees C [AID28486, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103310643 | | CID | 7302 | | Outcome | Unspecified | | BioAssay | Second-order rate constant (M-1 s-1) for the alkaline hydrolysis in water at 30 degrees C | | AID | 28486 | | BioAssay type | Literature | | Target | | | PubMed | 12061887 | | Data Table |  |
|
| 2 | [SID103310643] | Unspecified | | | Activity at human recombinant PON1 assessed as hydrolysis of lactone ring at 1 mM by Ellman's method [AID342465, Type: Literature] | Serum paraoxonase/arylesterase 1 [gi:308153572] |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103310643 | | CID | 7302 | | Outcome | Unspecified | | BioAssay | Activity at human recombinant PON1 assessed as hydrolysis of lactone ring at 1 mM by Ellman's method | | AID | 342465 | | BioAssay type | Literature | | Target | Serum paraoxonase/arylesterase 1 [gi:308153572] | | PubMed | 18572410 | | Data Table |  |
|
| 3 | [SID103310643] | Inactive | | | Binding affinity towards [3H]GHB binding site at 10 uM [AID71720, Type: Literature] | Gamma-hydroxybutyrate receptor [gi:81870762] |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103310643 | | CID | 7302 | | Outcome | Inactive | | BioAssay | Binding affinity towards [3H]GHB binding site at 10 uM | | AID | 71720 | | BioAssay type | Literature | | Target | Gamma-hydroxybutyrate receptor [gi:81870762] | | PubMed | 3361576 | | Data Table |  |
|
| 4 | [SID70860] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain [AID165, Type: other] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 70860 | | CID | 7302 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain | | AID | 165 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID70860] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the bub3 strain [AID167, Type: other] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 70860 | | CID | 7302 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the bub3 strain | | AID | 167 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID70860] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain [AID175, Type: other] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 70860 | | CID | 7302 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain | | AID | 175 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID70860] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID248, Type: other] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 70860 | | CID | 7302 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 248 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID70860] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain [AID161, Type: other] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 70860 | | CID | 7302 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain | | AID | 161 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID48413356] | Inactive | | | DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results [AID1189, Type: other] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 48413356 | | CID | 7302 | | Outcome | Inactive | | BioAssay | DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results | | AID | 1189 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID48413356] | Inactive | | | DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity [AID1194, Type: other] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 48413356 | | CID | 7302 | | Outcome | Inactive | | BioAssay | DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity | | AID | 1194 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID48413356] | Inactive | | | DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results [AID1199, Type: other] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 48413356 | | CID | 7302 | | Outcome | Inactive | | BioAssay | DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results | | AID | 1199 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID48413356] | Inactive | | | DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results [AID1205, Type: other] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 48413356 | | CID | 7302 | | Outcome | Inactive | | BioAssay | DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results | | AID | 1205 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID48413356] | Inactive | | | DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results [AID1208, Type: other] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 48413356 | | CID | 7302 | | Outcome | Inactive | | BioAssay | DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results | | AID | 1208 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID70860] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain [AID157, Type: other] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 70860 | | CID | 7302 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain | | AID | 157 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID70860] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the rad50 strain [AID155, Type: other] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 70860 | | CID | 7302 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the rad50 strain | | AID | 155 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID70860] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID256, Type: other] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 70860 | | CID | 7302 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 256 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|